RTW Biotech Opportunities Ltd Total Voting Rights
01 Luglio 2024 - 8:00AM
RNS Regulatory News
RNS Number : 4285U
RTW Biotech Opportunities Ltd
01 July 2024
LEI:
549300Q7EXQQH6KF7Z84
1 July 2024
RTW Biotech Opportunities
Ltd
(the "Company")
Total Voting
Rights
In accordance with
the FCA's Disclosure Guidance and Transparency Rule
5.6.1R the Company would like to notify the market of the
following:
At the close of business on 28 June
2024, the Company had 345,967,440 Ordinary shares in issue, of
which 10,253,791 were held in Treasury. Therefore, the total
number of voting rights in the Company was 335,713,649.
The above figure of 335,713,649 may
be used by Shareholders as the denominator for the calculations by
which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under
the FCA's Disclosure Guidance and Transparency
Rules.
For
Further Information:
|
RTW
Investments, LP
|
+44
(0)20 7959 6361
|
|
Woody Stileman, Managing
Director
Krisha McCune, Director, Investor
Relations
|
|
|
|
|
About RTW Biotech Opportunities Ltd:
RTW Biotech Opportunities Ltd (LSE:
RTW & RTWG) is an investment fund focused on identifying
transformative assets with high growth potential across the
biopharmaceutical and medical technology sectors. Driven by a
long-term approach to support innovative businesses, RTW Biotech
Opportunities Ltd invests in companies developing next-generation
therapies and technologies that can significantly improve patients'
lives. RTW Biotech Opportunities Ltd is managed by RTW Investments,
LP, a leading healthcare-focused
entrepreneurial investment firm with
deep scientific expertise and a strong track record of supporting
companies developing life-changing therapies.
Visit the website
at www.rtwfunds.com/rtw-biotech-opportunities-ltd for
more information.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
TVRZVLFLZQLXBBL
Grafico Azioni Rtw Biotech Opportunities (LSE:RTW)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni Rtw Biotech Opportunities (LSE:RTW)
Storico
Da Mar 2024 a Mar 2025
